These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34163549)

  • 1. The Association Between Hospital Length of Stay and Treatment With IV Magnesium in Patients With Status Migrainosus.
    Hoffman W; Aden J; Bossler R; Luster J; Jordan M
    Neurohospitalist; 2021 Jul; 11(3):235-240. PubMed ID: 34163549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Episodic status migrainosus: A novel migraine subtype.
    Singh TD; Cutrer FM; Smith JH
    Cephalalgia; 2018 Feb; 38(2):304-311. PubMed ID: 28056534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ziprasidone as a Potential Abortive Therapy for Status Migrainosus.
    Landsness EC; Wang LH; Bucelli RC
    Neurohospitalist; 2016 Oct; 6(4):151-156. PubMed ID: 27695596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of an Intravenous Dihydroergotamine Protocol for Refractory Migraine in Children.
    Theroux LM; Cappa R; Mendoza A; Mallawaarachchi I; Samanta D; Goodkin HP
    Headache; 2020 Sep; 60(8):1653-1663. PubMed ID: 32853454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences of an outpatient infusion center with intravenous magnesium therapy for status migrainosus.
    Xu F; Arakelyan A; Spitzberg A; Green L; Cesar PH; Csere A; Nworie O; Sahai-Srivastava S
    Clin Neurol Neurosurg; 2019 Mar; 178():31-35. PubMed ID: 30685601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Regional Anesthetic Sphenopalatine Ganglion Block on Self-Reported Pain in Patients With Status Migrainosus.
    Mehta D; Leary MC; Yacoub HA; El-Hunjul M; Kincaid H; Koss V; Wachter K; Malizia D; Glassman B; Castaldo JE
    Headache; 2019 Jan; 59(1):69-76. PubMed ID: 30043973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Profile and Prognosis of Youth With Status Migrainosus: Results From an Observational Study.
    Orr SL; Turner A; Kabbouche MA; Horn PS; O'Brien HL; Kacperski J; LeCates S; White S; Weberding J; Miller MN; Powers SW; Hershey AD
    Headache; 2020 May; 60(5):878-888. PubMed ID: 32031255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Prolonged Hospital Stay in Status Migrainosus.
    Modi SY; Dharaiya D; Katramados AM; Mitsias P
    Neurohospitalist; 2016 Oct; 6(4):141-146. PubMed ID: 27695594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine Treatment in Pregnant Women Presenting to Acute Care: A Retrospective Observational Study.
    Hamilton KT; Robbins MS
    Headache; 2019 Feb; 59(2):173-179. PubMed ID: 30403400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status migrainosus and migraine aura status in a French tertiary-care center: An 11-year retrospective analysis.
    Beltramone M; Donnet A
    Cephalalgia; 2014 Jul; 34(8):633-7. PubMed ID: 24504530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating status migrainosus in the emergency setting: what is the best strategy?
    Vécsei L; Szok D; Nyári A; Tajti J
    Expert Opin Pharmacother; 2018 Oct; 19(14):1523-1531. PubMed ID: 30198804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate and Predictors of Intractable Status Migrainosus among Patients Aged 13-18 Years.
    Goenka A; Fonseca LD
    Neurohospitalist; 2023 Jan; 13(1):5-12. PubMed ID: 36531843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short Term Oral Methylergonovine Maleate Prophylaxis for Status Migrainosus. Case Series and Review of Literature.
    Haque N; Tariq N
    Front Neurol; 2019; 10():201. PubMed ID: 30967829
    [No Abstract]   [Full Text] [Related]  

  • 14. The Use of a Pediatric Migraine Practice Guideline in an Emergency Department Setting.
    Kaar CR; Gerard JM; Nakanishi AK
    Pediatr Emerg Care; 2016 Jul; 32(7):435-9. PubMed ID: 26359823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Aura and Status Migrainosus on Readmissions for Vascular Events After Migraine Admission.
    Velickovic Ostojic L; Liang JW; Sheikh HU; Dhamoon MS
    Headache; 2018 Jul; 58(7):964-972. PubMed ID: 29933509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study.
    Baratloo A; Mirbaha S; Delavar Kasmaei H; Payandemehr P; Elmaraezy A; Negida A
    Korean J Pain; 2017 Jul; 30(3):176-182. PubMed ID: 28757917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Dose Magnesium Sulfate Infusion for Severe Asthma in the Emergency Department: Efficacy Study.
    Irazuzta JE; Paredes F; Pavlicich V; Domínguez SL
    Pediatr Crit Care Med; 2016 Feb; 17(2):e29-33. PubMed ID: 26649938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status migrainosus as an initial presentation of multiple sclerosis.
    Alroughani R; Ahmed SF; Khan R; Al-Hashel J
    Springerplus; 2015; 4():28. PubMed ID: 25646151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous magnesium as acute treatment for headaches: a pediatric case series.
    Gertsch E; Loharuka S; Wolter-Warmerdam K; Tong S; Kempe A; Kedia S
    J Emerg Med; 2014 Feb; 46(2):308-12. PubMed ID: 24182946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.